Results for tag: "Persistent Depressive Disorder Drug"

Persistent Depressive Disorder (PDD) is a type of depression that is characterized by a low mood and a lack of interest in activities that are usually enjoyable. It is a chronic condition that can last for years and can have a significant impact on a person's quality of life. Treatment for PDD typically involves a combination of psychotherapy and medication. Central Nervous System (CNS) drugs are used to treat a variety of mental health conditions, including PDD. These drugs work by altering the levels of neurotransmitters in the brain, which can help to reduce symptoms of depression. Commonly prescribed CNS drugs for PDD include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and tricyclic antidepressants (TCAs). The PDD drug market is highly competitive, with a number of major pharmaceutical companies offering products for the treatment of this condition. Some of the companies in this market include Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more